CXCR4-expressing CD90 + cells demonstrated enhanced migration towards sites of inflammation, tissue injury, or tumours, facilitating T-cell recruitment and activation and thereby promoting tissue repair, regeneration, and antitumor immunity. This evidence concerns the gene THY1 and neoplasm.